Connection

Barbara Tilley to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Barbara Tilley has written about Treatment Outcome.
Barbara Tilley
Connection Strength
0.467
Treatment Outcome
  1. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke. 1996 Nov; 27(11):2136-42.
    View in: PubMed
    Score: 0.060
  2. Retention of under-represented minorities in drug abuse treatment studies. Clin Trials. 2009 Jun; 6(3):252-60.
    View in: PubMed
    Score: 0.036
  3. Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial. Trials. 2022 Oct 06; 23(1):855.
    View in: PubMed
    Score: 0.023
  4. Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t-PA stroke trial. Stat Med. 2001 Jul 15; 20(13):1891-901.
    View in: PubMed
    Score: 0.021
  5. Intent-to-treat analysis of cluster randomized trials when clusters report unidentifiable outcome proportions. Clin Trials. 2020 12; 17(6):627-636.
    View in: PubMed
    Score: 0.019
  6. Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group. Arthritis Rheum. 1999 Sep; 42(9):1879-88.
    View in: PubMed
    Score: 0.018
  7. Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight. Ann Emerg Med. 1997 Nov; 30(5):676-82.
    View in: PubMed
    Score: 0.016
  8. Benefits of stroke treatment delivered using a mobile stroke unit trial. Int J Stroke. 2018 04; 13(3):321-327.
    View in: PubMed
    Score: 0.016
  9. Damage control laparotomy utilization rates are highly variable among Level I trauma centers: Pragmatic, Randomized Optimal Platelet and Plasma Ratios findings. J Trauma Acute Care Surg. 2017 03; 82(3):481-488.
    View in: PubMed
    Score: 0.015
  10. Damage-control resuscitation and emergency laparotomy: Findings from the PROPPR study. J Trauma Acute Care Surg. 2016 Apr; 80(4):568-74; discussion 574-5.
    View in: PubMed
    Score: 0.014
  11. Association of transfusion red blood cell storage age and blood oxygenation, long-term neurologic outcome, and mortality in traumatic brain injury. J Trauma Acute Care Surg. 2015 Nov; 79(5):843-9.
    View in: PubMed
    Score: 0.014
  12. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. JAMA. 2015 Feb 10; 313(6):584-93.
    View in: PubMed
    Score: 0.013
  13. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med. 1995 Jan 15; 122(2):81-9.
    View in: PubMed
    Score: 0.013
  14. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014 Nov 29; 384(9958):1929-35.
    View in: PubMed
    Score: 0.013
  15. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA. 2014 Jul 02; 312(1):36-47.
    View in: PubMed
    Score: 0.013
  16. Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation. Injury. 2014 Sep; 45(9):1287-95.
    View in: PubMed
    Score: 0.013
  17. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. JAMA Neurol. 2014 Jun; 71(6):710-6.
    View in: PubMed
    Score: 0.013
  18. The health education for lupus study: a randomized controlled cognitive-behavioral intervention targeting psychosocial adjustment and quality of life in adolescent females with systemic lupus erythematosus. Am J Med Sci. 2012 Oct; 344(4):274-82.
    View in: PubMed
    Score: 0.011
  19. Outcome variables in osteoporosis trials. Bone. 1992; 13 Suppl 1:S29-34.
    View in: PubMed
    Score: 0.011
  20. Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease. Mov Disord. 2010 Jun 15; 25(8):1082-6.
    View in: PubMed
    Score: 0.010
  21. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010 May 15; 375(9727):1695-703.
    View in: PubMed
    Score: 0.010
  22. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke. 2006 Oct; 37(10):2508-13.
    View in: PubMed
    Score: 0.007
  23. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke. 2006 Jul; 37(7):1798-804.
    View in: PubMed
    Score: 0.007
  24. Applying a phase II futility study design to therapeutic stroke trials. Stroke. 2005 Nov; 36(11):2410-4.
    View in: PubMed
    Score: 0.007
  25. Adjusting O'Brien's test to control type I error for the generalized nonparametric Behrens-Fisher problem. Biometrics. 2005 Jun; 61(2):532-9.
    View in: PubMed
    Score: 0.007
  26. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med. 2005 Apr; 45(4):377-84.
    View in: PubMed
    Score: 0.007
  27. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004 Mar 06; 363(9411):768-74.
    View in: PubMed
    Score: 0.006
  28. Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA Stroke Trial. Neurology. 2003 Oct 28; 61(8):1158-9.
    View in: PubMed
    Score: 0.006
  29. Pilot clinical trial of intravenous doxycycline versus placebo for rheumatoid arthritis. J Rheumatol. 2003 Jan; 30(1):41-3.
    View in: PubMed
    Score: 0.006
  30. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology. 2002 Sep 10; 59(5):669-74.
    View in: PubMed
    Score: 0.006
  31. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA. 2001 Dec 12; 286(22):2830-8.
    View in: PubMed
    Score: 0.005
  32. Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial. Stroke. 2000 Oct; 31(10):2335-41.
    View in: PubMed
    Score: 0.005
  33. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke. 1999 Aug; 30(8):1528-33.
    View in: PubMed
    Score: 0.005
  34. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med. 1999 Jun 10; 340(23):1781-7.
    View in: PubMed
    Score: 0.004
  35. Health outcomes among African American and Caucasian adults following a randomized trial of an asthma education program. Ethn Health. 1997 Nov; 2(4):329-39.
    View in: PubMed
    Score: 0.004
  36. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. J Rheumatol. 1997 Oct; 24(10):1910-5.
    View in: PubMed
    Score: 0.004
  37. Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. J Rheumatol. 1997 Jul; 24(7):1295-302.
    View in: PubMed
    Score: 0.004
  38. Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum. 1997 Mar; 40(3):419-25.
    View in: PubMed
    Score: 0.004
  39. Another look at minocycline. Bull Rheum Dis. 1996 Dec; 45(8):6-7.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.